Myriad Genetics, Inc. (MYGN)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$3.19-1.24%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · MYGN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | FY 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 782.2 | 824.5 | 824.5 | 837.6 | 678.4 | 690.6 | 557.1 | 638.6 | 851.1 | 743.7 | 771.4 | 753.8 | 723.1 | 778.2 | 613.2 | 496.0 | 402.1 |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | 771.4 | 753.8 | 723.1 | 778.2 | 613.2 | 496.0 | 402.1 |
| Cost of Revenues | 253.0 | 247.9 | 247.9 | 252.2 | 202.0 | — | — | — | — | — | 145.2 | 132.8 | 132.8 | 96.1 | 64.4 | 51.5 | 45.6 |
| Gross Profit | 529.2 | 576.6 | 576.6 | 585.4 | 476.4 | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | — | — | — | — | 514.7 | 537.8 | 496.9 | 507.3 | 556.6 | 435.0 | 439.9 | 359.2 | 366.0 | 327.1 | 251.8 | 208.4 | 169.8 |
| R&D Expenses | 104.2 | 106.8 | 106.8 | 113.4 | 85.4 | 81.9 | 73.3 | 77.2 | 85.9 | 70.8 | 74.4 | 70.6 | 75.5 | 67.5 | 53.7 | 42.6 | 27.8 |
| Other Operating Expenses, Total | — | — | — | — | — | — | — | — | — | — | — | — | — | — | (0.2) | (0.4) | (0.4) |
| Operating Income | (139.2) | (387.2) | (387.2) | (123.5) | (140.6) | (190.5) | (289.7) | (231.7) | 7.6 | 121.9 | 44.0 | 153.4 | 133.6 | 274.4 | 228.0 | 180.3 | 157.8 |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | — | 10.5 | 2.8 | 3.2 | 6.6 | 11.2 | 10.8 | 12.0 | 3.2 | 6.0 | — | — | — | — | — | — |
| Interest & Investment Income | 2.2 | 1.8 | 1.8 | 1.7 | 2.6 | 0.7 | 2.0 | 3.0 | 3.2 | 1.8 | 1.2 | 0.9 | 0.4 | 5.4 | 5.5 | 4.6 | 2.2 |
| Net Interest Expenses | — | — | — | — | 0.6 | 5.9 | 9.2 | 7.8 | 8.8 | 1.4 | 4.8 | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | (14.2) | (7.9) | (7.9) | — | 0.0 | 133.4 | 6.1 | 8.4 | (7.6) | (1.8) | (7.8) | 2.6 | 0.7 | 3.4 | — | — | — |
| Asset Writedown | — | 319.4 | 319.4 | 56.6 | 16.9 | — | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (153.4) | (395.1) | (395.1) | (123.5) | (140.6) | (57.1) | (283.6) | (223.3) | 0.0 | 120.1 | 36.2 | 156.0 | 134.3 | 277.9 | 233.3 | 184.5 | 159.7 |
| Income Tax Expense | — | (29.2) | (29.2) | 3.8 | (28.6) | (29.9) | (59.9) | (23.7) | (4.4) | (13.0) | 19.0 | 38.8 | 54.5 | 101.6 | 86.1 | 72.4 | 58.9 |
| Net Income | |||||||||||||||||
| Minority Interest | — | — | — | — | 0.0 | 0.0 | (0.1) | (0.1) | (0.2) | (0.2) | (0.2) | — | — | — | — | — | — |
| Net Income | (154.6) | (366.0) | (365.9) | (127.3) | (112.0) | (27.0) | (223.6) | (199.5) | 4.6 | 133.3 | 17.4 | 117.2 | 79.8 | 176.2 | 147.2 | 112.2 | 100.7 |
| Per Share | |||||||||||||||||
| Basic EPS | (1.63) | (3.95) | (3.95) | (1.41) | (1.39) | (0.35) | (2.99) | (2.69) | 0.06 | 1.92 | 0.25 | 1.67 | 1.12 | 2.33 | 1.82 | 1.33 | 1.12 |
| Diluted EPS | (1.63) | (3.95) | (3.95) | (1.41) | (1.39) | (0.35) | (2.99) | (2.69) | 0.06 | 1.85 | 0.25 | 1.60 | 1.07 | 2.25 | 1.77 | 1.30 | 1.10 |
| Revenue per Share | 8.25 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 94.8 | 92.6 | 92.6 | 90.6 | 80.6 | 78.0 | 74.8 | 74.3 | 73.5 | 69.4 | 68.3 | 70.0 | 71.3 | 75.7 | 80.9 | 84.6 | 89.8 |
| Diluted Weighted Avg Shares | 94.8 | 92.6 | 92.6 | 90.6 | 80.6 | 78.0 | 74.8 | 74.3 | 76.0 | 72.0 | 68.8 | 73.4 | 74.5 | 78.2 | 83.3 | 86.5 | 91.7 |
| Supplemental | |||||||||||||||||
| EBITDA | — | (333.5) | (333.5) | (62.3) | (87.9) | (127.7) | — | (159.7) | 80.6 | 176.3 | 92.3 | 180.2 | 158.6 | 288.2 | 236.9 | 189.4 | 165.0 |
| EBIT | (139.2) | (387.2) | (387.2) | (123.5) | (140.6) | (190.5) | (289.7) | (231.7) | 7.6 | 121.9 | 44.0 | 153.4 | 133.6 | 274.4 | 228.0 | 180.3 | 157.8 |
| Effective Tax Rate | — | 7.4% | — | — | 20.3% | 52.4% | 21.1% | 10.6% | — | -10.8% | 52.5% | 24.9% | 40.6% | 36.6% | 36.9% | 39.2% | 36.9% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.